SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-12-459014
Filing Date
2012-11-08
Accepted
2012-11-08 08:07:09
Documents
4
Period of Report
2012-11-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d433505d8k.htm 8-K 16253
2 PRESS RELEASE d433505dex991.htm EX-99.1 92284
3 GRAPHIC g433505pic1.jpg GRAPHIC 11054
4 GRAPHIC g433505pic2.jpg GRAPHIC 7204
  Complete submission text file 0001193125-12-459014.txt   135263
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51531 | Film No.: 121188491
SIC: 2834 Pharmaceutical Preparations